New drug combo aims to shrink advanced cervical tumors
NCT ID NCT07542717
First seen Apr 29, 2026 · Last updated May 20, 2026 · Updated 2 times
Summary
This study tests two experimental drugs, MRG003 and QL1706, together in people with recurrent or metastatic cervical cancer that has worsened after standard platinum chemotherapy. The goal is to see if the combination can shrink tumors. About 41 adults will take part. This is not a cure, but aims to control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT OR METASTATIC CERVICAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.